Trapidil inhibits human mesangial cell proliferation: Effect on PDGF β-receptor binding and expression

Kidney International

Volumn 46, Issue 4, 1994, Pages 1002-1009

  Gesualdo, Loreto ^a   Di Paolo, Salvatore ^a   Ranieri, Elena ^a   Schena, Francesco Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRAPIDIL;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0027973678     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1994.360     Document Type: Article

References (39)

1. ROSS R, RAINES EW, BOWEN-POPE DF: The biology of platelet derived growth factor. Cell 46:155-169, 1986
2. SHULTZ PJ, DICORLETO PE, SILVER BJ, ABBOUD HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 255:F674-F684, 1988
3. BARNES JL, HEVEY KA: Glomerular mesangial cell migration in response to platelet-derived growth factor. Lab Invest 62:379-382, 1990
4. ABBOUD HE: Platelet-derived growth factor and mesangial cells. Kidney Int 41:581-583, 1992
5. BISHAYEE S, MAJUNDAR S, KHIRE J, DAS M: Ligand-induced dimerization of the PDGF-receptors. J Biol Chem 264:11699-11905, 1989
6. ++, and contraction of mesangial cells. Am J Physiol 253:F458-F463, 1987
7. HART CE, FORSTROM JW, KELLY JD, SEIFERT RA, SMITH RA, ROSS R, MURRAY MJ, BOWRN-POPE DF: Two classes of PDGF receptors recognize different isoforms of PDGF. Science 240:1529-1531, 1988
8. RHEE SG, SUH PG, RYU SH, LEE SY: Studies of inositol phosphates and specific phospholipase C activity. Science 244:546-550, 1989
9. SEIFERT RA, HART CE, PHILIPS PE, FORSTROM JW, ROSS R, MURRAY M, BOWEN-POPE DF: Two different subunits associate to create isoform specific PDGF-receptors. J Biol Chem 264:8771-8778, 1989
10. WAHL MJ, OLASHAW NE, NISHIBE S, RHEE SG, PLEDGER WJ, CARPENTER G: Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in BALB/c 3T3 cells. Mol Cell Biol 9:2934-2943, 1989
11. KUMJIAN DA, WAHL MI, RHEE SG, DANIEL TO: PDGF binding promotes physical association of PDGF receptor with phospholipase C. Proc Natl Acad Sci USA 86:8232-8236, 1989
12. KUMJIAN DA, BARNSTEIN A, RHEE SG, DANIEL TO: Phospholipase C gamma complexes with ligand-activated PDGF-receptors. J Biol Chem 266:3973-3980, 1991
13. HELDIN CH, OSTMAN A, ERIKSSON A, SIEGBAHN A, CLAESSON-WELSH L, WESTERMARK B: Platelet-derived growth factor: Isoform-specific signalling via heterodimeric or homo-dimeric receptor complexes. Kidney Int 41:571-574, 1992
14. SILVER BJ, JAFFER FE, ABBOUD HE: Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci USA 86:1056-1060, 1989
15. KASHGARIAN M: Mesangium and glomerular disease. Kidney Int 17:141-154, 1980
16. MENÈ P, SIMONSON MS, DUNN MJ: Physiology of the mesangial cell. Physiol Rev 69:1347-1424, 1989
17. ROSEN S: Classification of glomerular disease, in The Pathology of Glomerular Disease, edited by S ROSEN, New York, Churchill Livingstone, 1983, pp 1-10
18. FRAMPTON G, HILDRETH G, CAMERON JS: Could platelet derived growth factor have a role in the pathogenesis of lupus nephritis? Lancet 2:343, 1988
19. FELLSTROM B, KLARESKOG L, HELDIN CH, LARSSON E, RONNSTRAND L, TERRACIO L, TUFVESON G, WAHLBERG J, RUBIN K: Platelet-derived growth factor receptors in the kidney. Up-regulated expression in inflammation. Kidney Int 36:1099-1102, 1989
20. GESUALDO L, PINZANI M, FLORIANO J, HASSAN MO, NAGY MU, SCHENA FP, EMANCIPATOR SN, ABBOUD HE: Platelet derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991
21. IIDA H, SEIFERT R, ALPERS CE, GRONWALD RG, PHILLIPS PE, PRITZL P, GORDON K, GOWN A, ROSS R, BOWN-POPE D, JOHNSON R: Platelet-derived growth factor and PDGF receptor expression in mesangial proliferative nephritis. Proc Natl Acad Sci USA 88:6560-6564, 1991
22. YOSHIMURA A, GORDON K, ALPERS CE, FLOEGE AJ. PRITZL P, ROSS R, COUSER WG, BOWEN-POPE DF, JOHNSON RJ: Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int 40:470-476, 1992
23. FLOEGE J, BURNS M, ALPERS C, YOSHIMURA A, PRITZEL P, GORDON K, SEIFERT R, BOWEN-POPE D, COUSER W, JOHNSON R: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
24. GESUALDO L, RANIERI E, PANNARALE G, DI PAOLO S, SCHENA FP: Platelet derived growth factor and proliferative glomerulonephritis. Kidney Int 539:86-89, 1993
25. KOSUZUME H, SAITO A, ONISHI H: Influence and mode of action of trapymin, an agent for ischemic heart disease on edematous reactions of artery, platelet aggregation and erythrocyte deformability. J Med Soc Toho 26:674-685, 1979
26. SUZUKI Y: Antithrombotic activity and the mechanism of action of Trapidil. Prostaglandins Leukot Med 9:685-691, 1982
27. ONISHI H, YAMAGUCHI K, SHIMADA S, SUZUKI Y, KUMAGAI A: A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet derived growth factor. Life Sci 28:1641-1646, 1981
28. TIELL M, SUSSMAN II, GORDON PB, SAUNDERS RN: Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil. Artery 11:33-50, 1983
29. LIU MW, ROUBIN GS, ROBINSON KA, BLACK AJ, KINGS SB: Trapidil, a platelet-derived growth factor (PDGF) antagonist in preventing restenosis after angioplasty in the atherosclerotic rabbit. (abstract) Circulation 78:A230, 1988
30. KURATSU J, USHIO Y: Antiproliferative effect of Trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro. J Neurosurg 73:436-440, 1990
31. CERCEK B, EBRAHIMI R, DIMAYUGA P, KHORSANDI M, FORRESTER JS: Trapidil prevents rat vascular smooth cell proliferation in vitro and in vivo. J Am Coll Cardiol 17:72A, 1991
32. QUADRACCI LJ, STRIKER GE: Growth and maintainance of glomerular cells in vitro. Proc Soc Exp Biol Med 135:974-979, 1970
33. DI PAOLO S, LATTANZI V, GLIASTAMACCHIA E, VINCENTI C, BALICE AM, MONTANARO N, NARDELLI GM, GIORGINO R: Extreme insulin resistance due to anti-insulin receptor antibodies: A direct demonstration of autoantibody secretion by peripheral lymphocytes. Diabetes Res Clin Pract 9:65-73, 1990
34. DI PAOLO S, GIORGINO R: Insulin resistance and hypoglicemia in a patient with systemic lupus erythematosus: Description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. J Clin Endocrinol Metab 73:650-657, 1991
35. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
36. CLAESSON-WELSH L, ERIKSSON A, MOREN A, SEVERINSSON L, EK B, OSTMAN A, BETSHOLTZ C, HELDIN CH: cDNA cloning and expression of a human platelet derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8:3476-3486, 1988
37. JAFFER F, SAUNDERS C, SHULTZ P, THROCKMORTON D, WEINSHELL E, ABBOUD HE: Regulation of mesangial cell growth by polypeptide mitogens. Am J Pathol 135:261-269, 1989
38. VASSBOTN FS, OSTMAN A, SIEGBAHN A, HOLMSEN H, HELDIN C-H: Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF-α and β-receptor signals in cells expressing both receptor types. J Biol Chem 267:15635-15641, 1992
39. GESUALDO L, MILANI S, DI PAOLO S, GRAPPONE C, RANIERI E, PINZANI M, MAFFEI T, SCHENA FP: Platelet derived growth factor receptor expression in normal and glomerulonephritic human kidney: An immunohistochemistry and in situ hybridization study. J Am Soc Nephrol 4:678A, 1993